Thyrotropin receptor antibodies and Graves’ orbitopathy

CONTEXT AND PURPOSE: The thyrotropin receptor (TSHR) is the key autoantigen in Graves’ disease (GD) and associated orbitopathy (GO). Antibodies targeting the TSHR (TSHR-Ab) impact the pathogenesis and the course of GO. This review discusses the role and clinical relevance of TSHR-Ab in GO. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Diana, T., Ponto, K. A., Kahaly, G. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Short Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310479/
https://www.ncbi.nlm.nih.gov/pubmed/32749654
http://dx.doi.org/10.1007/s40618-020-01380-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310479/
https://www.ncbi.nlm.nih.gov/pubmed/32749654
http://dx.doi.org/10.1007/s40618-020-01380-9

Ejemplares similares